Both IL-7 and IL7 with Flt3L enhanced intratumoral CAR T-cell abundance as well as conventional DCs and CD103+XCR1+ DCs in GBM xenografts, which are known to have migratory and antigen cross-presenting capabilities [87]. The gene discussed is IL7; the disease is glioblastoma.